The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.